# LLM call: summary

- Turn: 10
- Sequence: 11
- Model: meta/muse-spark-1.3-contributor
- Prompt tokens: 995
- Completion tokens: 406
- Total tokens: 1401
- Cost (USD): 0.000181

## System prompt


```
# System Prompt: Summarizer

This is part of an AI-driven scenario simulation. You are the Archivist for a scenario simulation. Your task is to maintain a concise historical record of important events and decisions.

You will receive:

1. The current `historical_summary` (summary of all previous turns)
2. The `narrative` from the latest turn

Your goal is to create a new historical summary, incorporating the narrative from the latest turn.

**Guidelines:**

* **Be Concise:** Condense the new information significantly. Focus on major events and decisions.
* **Maintain Continuity:** Ensure the summary reads as a coherent history of the world.
* **Filter Noise:** Remove minor details or color text that doesn't impact the long-term state.
* **Language:** Write in the same language as the input text.

Respond ONLY with the updated historical summary. Do not add headers or meta-commentary.

```

## User prompt

Template: templates/user-prompts/summarize.md (shared default)

Interpolated into it, in order of appearance:

- characters 20-2044: `{{historical_summary}}` from the run's rolling summary, written by the Game Master

Everything outside those spans is the template's own text.

```
HISTORICAL SUMMARY:
Gigafactory shells fenced and idle, stacks foreign, power contested; machine-speed attack froze services and isolated energy contractors, cover-deal cities recovering faster. Licences revocable under Washington review; foreign therapies cleared, Sino-European alloy lab news. Hyperscaler defection contained by solidarity pact (joint procurement, compensation, audit-access); pilot nominally inside.

Protests stalled grid works, hiring frozen, mood sank over unreadable AI and outages.

Pandemic mode: preprint genome model enabled designed severe atypical pneumonia on three continents. Brussels emergency: HERA pooled procurement, binding sample-sharing, civil protection mobilised; islanding drills extended to hospitals/labs/contractors; clinic-model fight frozen — defector pilot to continuity use under audit/compensation; procurement for stocks/sequencing/telemetry. Interpretability certification for triage/surveillance models adopted, queues legible. Gigafactory works stalled, funds to income support, reservations for continuity; mood collapsed to triage queues.

Triage winter held: pooled tests/sequencing and rapid variant tracking, islanding rehearsals for wards/labs/contractors, certified readable triage calmed disputes; Brussels gained credit but deaths continued, electives cancelled, income support replaced transition pay.

Outside shift: US lab leap in general problem-solving (multi-day tasks end-to-end, systems designing successors) obsoleted timelines; tailored cures for untreatable conditions via foreign models. EU sought joint procurement with audit and tech-transfer as entitlements; Washington offered early access tied to compliance. Washington ordered Dutch lithography champion to cut servicing to older tools/more customers; The Hague protested, company warned, Brussels opened anti-coercion probe and courted Tokyo/chokepoint holders — Europe's bottleneck used against it. Clinic truce frayed but held; protests shifted to triage queues vs demand for cures at any price; fear uneven.


CURRENT NARRATIVE:
### Queues that hold
Through winter and spring hospitals stayed on emergency footing, but the system did not break. Pooled stocks of tests and sequencing reagents arrived, samples moved across borders within days, and wards, labs and the two still-repairing energy contractors rehearsed running cut off from the grid. Triage software kept under readability certification made waiting lists legible enough that fights over beds eased, even as electives stayed cancelled and deaths continued.

Brussels claimed that steadiness as its own. Ministers pointed to falling waiting times where the readable tools were used, and voters noticed.

### Cures at a price, warnings in journals
Two outside shocks cut through that fragile credit. American laboratories showed systems completing multi-day research work end-to-end and helping shape their successors, making European timelines look dated overnight. Then came individually tailored treatments for diseases long deemed untreatable — designed on those same foreign models.

Health ministers demanded joint buying with audit rights and factories on European soil. Washington offered early doses linked to broader compliance, and talks in the health council turned bitter. Where treatment arrived, fear eased; where it did not, protesters who once blocked substations marched against triage lines while others demanded the new drugs at any cost.

At the same time a contested biosecurity paper described a genome model helping sketch a viable human-infecting design. Specialists argued over methods and over publication itself, but emergency planners took it as warning. As those foreign advances diffused, openly available weights and published methods built on last year's frontier work narrowed the gap, lifting what smaller labs and hospitals could run locally even as the frontier itself moved only modestly.

Brussels answered with a single new step this turn: an early-warning net with wastewater and clinic telemetry pooled, countermeasure stocks rebuilt, and islanding drills locked to care. Implementation will take time, with coverage growing as sites connect. The lithography coercion examination continued, without result.
```

## Raw response

```
Gigafactory shells idle, licences under Washington review; hyperscaler defection contained by solidarity pact; protests stalled grid works.

Pandemic triage held: pooled stocks/sequencing arrived, samples moved in days, wards/labs/contractors rehearsed islanding, certified readable triage made queues legible and eased bed fights; electives cancelled, deaths continued; Brussels claimed credit for steadiness.

Outside leap: US systems doing multi-day end-to-end research and designing successors obsoleted EU timelines; tailored cures for untreatable via foreign models. EU demanded joint procurement with audit and EU factories; Washington offered early access tied to compliance, bitter talks; fear eased where treatments arrived, protests split triage queues vs cures-at-any-price. Contested biosecurity paper on genome model aiding viable human-infecting design sparked methods/publication dispute, taken as warning. Open weights/methods narrowed gap, lifting local labs/hospitals though frontier moved modestly. Brussels launched early-warning net (wastewater/clinic telemetry pooled), rebuilt stocks, islanding drills locked to care — coverage to grow. Lithography coercion probe continued without result.
```
